Investmark Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Investmark Advisory Group's ABBV Position: Q2 2026 in Review
Investmark Advisory Group reduced its AbbVie (ABBV) stake by 0.2% in Q2 2026, selling an estimated $9.9K and leaving 23,094 shares worth $5.81M. The position accounts for 2.21% of the portfolio, ranked #8.
Investmark Advisory Group first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Investmark Advisory Group held 23,094 shares of AbbVie worth $5.81M as of Q2 2026.
- Investmark Advisory Group sold 46 AbbVie shares in Q2 2026, an estimated $9.9K.
- AbbVie made up 2.21% of Investmark Advisory Group's portfolio in Q2 2026, its #8 holding.
- Investmark Advisory Group first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Investmark Advisory Group's 13F filing for Q2 2026, filed 7 Aug 2026.